Insights

Platform Scaling Longevity InTime is raising funds to scale its clinical trial simulation platform. Business development teams could explore needs around cloud infrastructure, data pipelines, cybersecurity, and scalable AI operations.

Biotech Partnerships The company targets longevity biotechs seeking to reduce trial risk and accelerate development. Clinical research organizations, biotech service providers, and trial technology vendors may find partnership or integration opportunities.

Regulatory Readiness Its platform aims to help teams design trials, predict success, and reduce regulatory risk. Regulatory consulting firms and clinical data specialists could offer complementary services to support evidence generation and FDA submissions.

Data Capabilities Longevity InTime also works on disease prediction and structuring instructed medical data. Healthcare data providers, medical AI companies, and research institutions may be potential collaborators or customers for data access and tooling.

Commercial Growth The company reports $10M to $25M in revenue, has raised $2.4M, and employs 11 to 50 people. This combination suggests potential demand for sales enablement, recruiting, and go to market services as it expands its platform and ecosystem.

Similar companies to Longevity InTime

Longevity InTime Tech Stack

Longevity InTime uses 8 technology products and services including Google Ads, LinkedIn Ads, VK Pixel, and more. Explore Longevity InTime's tech stack below.

Longevity InTime's Email Address Formats

Longevity InTime uses at least 3 email formats:
Longevity InTime Email FormatsExamplePercentage
First@intime.digitalJohn@intime.digital
50%
Last@intime.digitalDoe@intime.digital
33%
LastFirst@intime.digitalDoeJohn@intime.digital
17%

Frequently Asked Questions

What is Longevity InTime's official website and social media links?

Minus sign iconPlus sign icon
Longevity InTime's official website is longevityintime.org and has social profiles on LinkedIn and Crunchbase.

How much revenue does Longevity InTime generate?

Minus sign iconPlus sign icon
As of November 2026, Longevity InTime's annual revenue is estimated to be $10M - $25M.

What is Longevity InTime's SIC code and NAICS code?

Minus sign iconPlus sign icon
Longevity InTime's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Longevity InTime have currently?

Minus sign iconPlus sign icon
As of November 2026, Longevity InTime has approximately 20 employees across 4 continents, including Asia, Europe and North America. Key team members include Independent Owner: O. T., Advisor: J. L. C. and Aws Devops Engineer: A. Y. Explore Longevity InTime's employee directory with LeadIQ.

What industry does Longevity InTime belong to?

Minus sign iconPlus sign icon
Longevity InTime operates in the Biotechnology Research industry.

What technology does Longevity InTime use?

Minus sign iconPlus sign icon
Longevity InTime's tech stack includes Google Ads, LinkedIn Ads, VK Pixel, Calendly, Amazon Web Services, cdnjs, Google Fonts API and Vercel.

What is Longevity InTime's email format?

Minus sign iconPlus sign icon
Longevity InTime's email format typically follows the pattern of First@intime.digital. Find more Longevity InTime email formats with LeadIQ.

How much funding has Longevity InTime raised to date?

Minus sign iconPlus sign icon
As of November 2026, Longevity InTime has raised $2.4M in funding. The last funding round occurred on Jan 22, 2020 for $100K.

When was Longevity InTime founded?

Minus sign iconPlus sign icon
Longevity InTime was founded in 2018.
Longevity InTime logo

Longevity InTime

Biotechnology ResearchDelaware, United States11-50 Employees

Longevity InTime BioTech develops an AI-driven platform that simulates clinical trials to de-risk human studies and accelerate regulatory decisions. The system runs hundreds of blinded trial scenarios to help longevity-focused biotechs optimize trial design, estimate success probabilities, and reduce regulatory risk. By applying causal AI, the company aims to enable faster and cheaper development of aging therapies, targeting the first generation of approved treatments in this area. All methods are proprietary and patent-pending, with priority claims in the field, and the firm pursues related work in disease prediction and organizing medical data. 

Headquartered in Wilmington, Delaware, the company operates with a small-to-mid-sized team within the biotechnology research sector. Its approach centers on AI-assisted trial design for aging-related therapies, underpinned by patent-pending methodologies intended to accelerate the path to approval.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
11-50

Section iconFunding & Financials

  • $2.4M

    Longevity InTime has raised a total of $2.4M of funding over 3 rounds. Their latest funding round was raised on Jan 22, 2020 in the amount of $100K as a Pre Seed.

  • $10M - $25M

    Longevity InTime's revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.